News

The latest press releases, publications, and events for Innoviva Specialty Therapeutics

Filter by:

All News Press Releases Events

06.24.2024

Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018

Read More

06.24.2024

Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline

Read More

06.24.2024

Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials

Read More

06.24.2024

Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials.

Read More

06.03.2023

In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer

Read More

11.13.2020

Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials

Read More

09.25.2020

In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae

Read More

10.01.2019

Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration

Read More

10.01.2019

Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance

Read More

06.20.2019

Activity of cefiderocol (CFDC), ceftazidime-avibactam (CZA), and eravacycline (ERV) against carbapenem-resistant (CR) E. coli isolates from the US: Clonal Background, Resistance Genes, and Co-Resistance

Read More